The global microbial fermentation market size is calculated at USD 36.29 billion in 2025 and is forecasted to reach around USD 62.01 billion by 2034, accelerating at a CAGR of 6.14% from 2025 to 2034. The Asia Pacific microbial fermentation market size surpassed USD 17.06 billion in 2025 and is expanding at a CAGR of 6.25% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Microbial Fermentation Technology Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Microbial Fermentation Technology Market, by Application
8.1.1. Enzymes
8.1.1.1. Market Revenue and Forecast
8.1.2. Probiotics Supplements
8.1.2.1. Market Revenue and Forecast
8.1.3. Monoclonal Antibodies
8.1.3.1. Market Revenue and Forecast
8.1.4. Biosimilars
8.1.4.1. Market Revenue and Forecast
8.1.5. Antibiotics
8.1.5.1. Market Revenue and Forecast
8.1.6. Vaccines
8.1.6.1. Market Revenue and Forecast
8.1.7. Recombinant Proteins
8.1.7.1. Market Revenue and Forecast
8.1.8. Small Molecules
8.1.8.1. Market Revenue and Forecast
9.1. Microbial Fermentation Technology Market, by End-User
9.1.1. Bio-Pharmaceutical Companies
9.1.1.1. Market Revenue and Forecast
9.1.2. CMOs & CDMOs
9.1.2.1. Market Revenue and Forecast
9.1.3. Contract Research Organizations (CROs)
9.1.3.1. Market Revenue and Forecast
9.1.4. Academic & Research Institutes
9.1.4.1. Market Revenue and Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Application
10.1.2. Market Revenue and Forecast, by End-User
10.1.3. U.S.
10.1.3.1. Market Revenue and Forecast, by Application
10.1.3.2. Market Revenue and Forecast, by End-User
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Forecast, by Application
10.1.4.2. Market Revenue and Forecast, by End-User
10.2. Europe
10.2.1. Market Revenue and Forecast, by Application
10.2.2. Market Revenue and Forecast, by End-User
10.2.3. UK
10.2.3.1. Market Revenue and Forecast, by Application
10.2.3.2. Market Revenue and Forecast, by End-User
10.2.4. Germany
10.2.4.1. Market Revenue and Forecast, by Application
10.2.4.2. Market Revenue and Forecast, by End-User
10.2.5. France
10.2.5.1. Market Revenue and Forecast, by Application
10.2.5.2. Market Revenue and Forecast, by End-User
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Forecast, by Application
10.2.6.2. Market Revenue and Forecast, by End-User
10.3. APAC
10.3.1. Market Revenue and Forecast, by Application
10.3.2. Market Revenue and Forecast, by End-User
10.3.3. India
10.3.3.1. Market Revenue and Forecast, by Application
10.3.3.2. Market Revenue and Forecast, by End-User
10.3.4. China
10.3.4.1. Market Revenue and Forecast, by Application
10.3.4.2. Market Revenue and Forecast, by End-User
10.3.5. Japan
10.3.5.1. Market Revenue and Forecast, by Application
10.3.5.2. Market Revenue and Forecast, by End-User
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Forecast, by Application
10.3.6.2. Market Revenue and Forecast, by End-User
10.4. MEA
10.4.1. Market Revenue and Forecast, by Application
10.4.2. Market Revenue and Forecast, by End-User
10.4.3. GCC
10.4.3.1. Market Revenue and Forecast, by Application
10.4.3.2. Market Revenue and Forecast, by End-User
10.4.4. North Africa
10.4.4.1. Market Revenue and Forecast, by Application
10.4.4.2. Market Revenue and Forecast, by End-User
10.4.5. South Africa
10.4.5.1. Market Revenue and Forecast, by Application
10.4.5.2. Market Revenue and Forecast, by End-User
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Forecast, by Application
10.4.6.2. Market Revenue and Forecast, by End-User
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Application
10.5.2. Market Revenue and Forecast, by End-User
10.5.3. Brazil
10.5.3.1. Market Revenue and Forecast, by Application
10.5.3.2. Market Revenue and Forecast, by End-User
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Forecast, by Application
10.5.4.2. Market Revenue and Forecast, by End-User
11.1. Abolis Biotechnologies
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. ABPDU
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. AGC Biologics
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Bio-CAT Microbials
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Bio-Technical Resources
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Biocatalysts
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Bluestem Biosciences
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. EKF Diagnostics
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Fujifilm Diosynth
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Microbial Discovery Group
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
13.1. About Us
13.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample